Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Glaxo Laboratories Pakistan Ltd, commonly referred to as Glaxo Pakistan, is a prominent player in the pharmaceutical industry, headquartered in Karachi, Pakistan. Established in 1951, the company has made significant strides in providing innovative healthcare solutions across the region, with a strong presence in major operational areas including Lahore and Islamabad.
Specialising in prescription medicines, vaccines, and consumer healthcare products, Glaxo Pakistan is renowned for its commitment to quality and research-driven development. The company’s core offerings include well-known brands in therapeutic areas such as respiratory, infectious diseases, and vaccines, setting it apart in a competitive market.
With a legacy of over seven decades, Glaxo Laboratories Pakistan has achieved notable milestones, including numerous awards for excellence in pharmaceutical manufacturing. Its dedication to improving health outcomes positions it as a trusted leader in the industry, contributing significantly to the healthcare landscape of Pakistan.
+58 vs industry average
Glaxo Laboratories Pakistan Ltd’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Glaxo Laboratories Pakistan Ltd yet.
Glaxo Laboratories Pakistan Ltd, headquartered in PK, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is part of a corporate family that cascades its climate commitments and performance data from its parent organisation, GSK plc, at a cascade level of 4.
While specific reduction targets or achievements for Glaxo Laboratories Pakistan Ltd are not available, it is important to note that the overarching climate initiatives and commitments are inherited from GSK plc. This includes participation in various sustainability frameworks such as the Science Based Targets initiative (SBTi), CDP, and RE100, which aim to drive significant reductions in greenhouse gas emissions across their operations.
As part of GSK plc's commitment to climate action, the company is focused on reducing its carbon footprint and enhancing sustainability practices. However, without specific data from Glaxo Laboratories Pakistan Ltd, the exact impact and progress of these initiatives at the local level remain unspecified.
No climate goals have been disclosed for Glaxo Laboratories Pakistan Ltd yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Glaxo Laboratories Pakistan Ltd yet.
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more